The tumor suppressor folliculin regulates AMPK-dependent metabolic transformation

Ming Yan, Marie Claude Gingras, Elaine A. Dunlop, Yann Nouët, Fanny Dupuy, Zahra Jalali, Elite Possik, Barry J. Coull, Dmitri Kharitidi, Anders Bondo Dydensborg, Brandon Faubert, Miriam Kamps, Sylvie Sabourin, Rachael S. Preston, David Mark Davies, Taren Roughead, Laëtitia Chotard, Maurice A. M. Van Steensel, Russell Jones, Andrew R. TeeArnim Pause

Research output: Contribution to journalArticle

78 Citations (Scopus)

Abstract

The Warburg effect is a tumorigenic metabolic adaptation process characterized by augmented aerobic glycolysis, which enhances cellular bioenergetics. In normal cells, energy homeostasis is controlled by AMPK; however, its role in cancer is not understood, as both AMPK-dependent tumor-promoting and -inhibiting functions were reported. Upon stress, energy levels are maintained by increased mitochondrial biogenesis and glycolysis, controlled by transcriptional coactivator PGC-1α and HIF, respectively. In normoxia, AMPK induces PGC-1α, but how HIF is activated is unclear. Germline mutations in the gene encoding the tumor suppressor folliculin (FLCN) lead to Birt-Hogg-Dubé (BHD) syndrome, which is associated with an increased cancer risk. FLCN was identified as an AMPK binding partner, and we evaluated its role with respect to AMPK-dependent energy functions. We revealed that loss of FLCN constitutively activates AMPK, resulting in PGC-1α-mediated mitochondrial biogenesis and increased ROS production. ROS induced HIF transcriptional activity and drove Warburg metabolic reprogramming, coupling AMPK-dependent mitochondrial biogenesis to HIF-dependent metabolic changes. This reprogramming stimulated cellular bioenergetics and conferred a HIF-dependent tumorigenic advantage in FLCN-negative cancer cells. Moreover, this pathway is conserved in a BHD-derived tumor. These results indicate that FLCN inhibits tumorigenesis by preventing AMPK-dependent HIF activation and the subsequent Warburg metabolic transformation.

Original languageEnglish
Pages (from-to)2640-2650
Number of pages11
JournalJournal of Clinical Investigation
Volume124
Issue number6
Early online date24 Apr 2014
DOIs
Publication statusPublished - Jun 2014

Fingerprint Dive into the research topics of 'The tumor suppressor folliculin regulates AMPK-dependent metabolic transformation'. Together they form a unique fingerprint.

  • Cite this

    Yan, M., Gingras, M. C., Dunlop, E. A., Nouët, Y., Dupuy, F., Jalali, Z., Possik, E., Coull, B. J., Kharitidi, D., Dydensborg, A. B., Faubert, B., Kamps, M., Sabourin, S., Preston, R. S., Davies, D. M., Roughead, T., Chotard, L., Van Steensel, M. A. M., Jones, R., ... Pause, A. (2014). The tumor suppressor folliculin regulates AMPK-dependent metabolic transformation. Journal of Clinical Investigation, 124(6), 2640-2650. https://doi.org/10.1172/JCI71749